The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Open accessAbstract
BACKGROUND: The burden of inflammatory bowel disease (IBD) is rising globally, with substantial variation in levels and trends of disease in different countries and regions. Understanding these geographical differences is crucial for formulating effective strategies for preventing and treating IBD. We report the prevalence, mortality, and overall burden of IBD in 195 countries and territories between 1990 and 2017, based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017. METHODS: We modelled mortality due to IBD using a standard Cause of Death Ensemble model including data mainly from vital registrations. To estimate the non-fatal burden, we used data presented in primary studies, hospital discharges, and claims data, and used DisMod-MR 2.1, a Bayesian meta-regression tool, to ensure consistency between measures. Mortality, prevalence, years of life lost (YLLs) due to premature death, years lived with disability (YLDs), and disability-adjusted life-years (DALYs) were estimated. All of the estimates were reported as numbers and rates per 100 000 population, with 95% uncertainty intervals (UI). FINDINGS: In 2017, there were 6·8 million (95% UI 6·4-7·3) cases of IBD globally. The age-standardised prevalence rate increased from 79·5 (75·9-83·5) per 100 000 population in 1990 to 84·3 (79·2-89·9) per 100 000 population in 2017. The age-standardised death rate decreased from 0·61 (0·55-0·69) per 100 000 population in 1990 to 0·51 (0·42-0·54) per 100 000 population in 2017. At the GBD regional level, the highest age-standardised prevalence rate in 2017 occurred in high-income North America (422·0 [398·7-446·1] per 100 000) and the lowest age-standardised prevalence rates were observed in the Caribbean (6·7 [6·3-7·2] per 100 000 population). High Socio-demographic Index (SDI) locations had the highest age-standardised prevalence rate, while low SDI regions had the lowest age-standardised prevalence rate. At the national level, the USA had the highest age-standardised prevalence rate (464·5 [438·6-490·9] per 100 000 population), followed by the UK (449·6 [420·6-481·6] per 100 000). Vanuatu had the highest age-standardised death rate in 2017 (1·8 [0·8-3·2] per 100 000 population) and Singapore had the lowest (0·08 [0·06-0·14] per 100 000 population). The total YLDs attributed to IBD almost doubled over the study period, from 0·56 million (0·39-0·77) in 1990 to 1·02 million (0·71-1·38) in 2017. The age-standardised rate of DALYs decreased from 26·5 (21·0-33·0) per 100 000 population in 1990 to 23·2 (19·1-27·8) per 100 000 population in 2017. INTERPRETATION: The prevalence of IBD increased substantially in many regions from 1990 to 2017, which might pose a substantial social and economic burden on governments and health systems in the coming years. Our findings can be useful for policy makers developing strategies to tackle IBD, including the education of specialised personnel to address the burden of this complex disease. FUNDING: Bill & Melinda Gates Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Though historically, IBD was considered to affect predominantly people of European ancestry, it is now increasingly recognized in diverse groups.2”
From Culturally Informed Digital Behavioral Intervention Development for Inflammatory Bowel Disease: A Qualitative Study (2025) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“IBD is increasingly recognized in diverse populations,2,32 and patients’ sense of an increase in awareness of IBD in their communities now compared to in the past may be due to their own perception of awareness since receiving their diagnosis or reflect this increasing incidence.”
From Culturally Informed Digital Behavioral Intervention Development for Inflammatory Bowel Disease: A Qualitative Study (2025) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Self-citationVos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Self-citationRoth, G. A., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32203-7 · Cited by 8,600
Self-citationNg, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087
The global burden of IBD: from 2015 to 2025
Kaplan, G. G. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.150 · Cited by 2,639
Inflammatory bowel disease: cause and immunobiology
Baumgart, D. C., & Carding, S. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60750-8 · Cited by 2,147
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Kostic, A. D., Xavier, R. J., & Gevers, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.009 · Cited by 1,789
Dignass, A., Lindsay, J. O., Sturm, A., Windsor, A., Colombel, J.-F., Allez, M., D'Haens, G., D'Hoore, A., Mantzaris, G., Novacek, G., et al. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.09.002 · Cited by 1,548
Dignass, A., Van Assche, G., Lindsay, J. O., Lémann, M., Söderholm, J., Colombel, J. F., Danese, S., D'Hoore, A., Gassull, M., Gomollón, F., et al. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.12.002 · Cited by 1,498
The burden of inflammatory bowel disease in Europe
Burisch, J., Jess, T., Martinato, M., & Lakatos, P. L. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2013.01.010 · Cited by 961
Cited by
The sirtuin family in health and disease
Wu, Q.-J., Zhang, T.-N., Chen, H.-H., Yu, X.-F., Lv, J.-L., Liu, Y.-Y., Liu, Y.-S., Zheng, G., Zhao, J.-Q., Wei, Y.-F., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01257-8 · Cited by 862
Wang, R., Li, Z., Liu, S., & Zhang, D. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-065186 · Cited by 597
Dolinger, M., Torres, J., & Vermeire, S. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02586-2 · Cited by 580
Calprotectin: from biomarker to biological function
Jukic, A., Bakiri, L., Wagner, E. F., Tilg, H., & Adolph, T. E. (2021) · Gut · doi:10.1136/gutjnl-2021-324855 · Cited by 500
Cao, F., Jin, L., Gao, Y., Ding, Y., Wen, H., Qian, Z., Zhang, C., Hong, L., Yang, H., Zhang, J., et al. (2023) · Nature Nanotechnology · doi:10.1038/s41565-023-01346-x · Cited by 472
Metadata
- Authors
- Alatab, S., Sepanlou, S. G., Ikuta, K., Vahedi, H., Bisignano, C., Safiri, S., Sadeghi, A., Nixon, M. R., Abdoli, A., Abolhassani, H., Alipour, V., Almadi, M. A. H., Almasi-Hashiani, A., Anushiravani, A., Arabloo, J., Atique, S., Awasthi, A., Badawi, A., Baig, A. A. A., Bhala, N., Bijani, A., Biondi, A., Borzì, A. M., Burke, K. E., Carvalho, F., Daryani, A., Dubey, M., Eftekhari, A., Fernandes, E., Fernandes, J. C., Fischer, F., Haj-Mirzaian, A., Haj-Mirzaian, A., Hasanzadeh, A., Hashemian, M., Hay, S. I., Hoang, C. L., Househ, M., Ilesanmi, O. S., Jafari Balalami, N., James, S. L., Kengne, A. P., Malekzadeh, M. M., Merat, S., Meretoja, T. J., Mestrovic, T., Mirrakhimov, E. M., Mirzaei, H., Mohammad, K. A., Mokdad, A. H., Monasta, L., Negoi, I., Nguyen, T. H., Nguyen, C. T., Pourshams, A., Poustchi, H., Rabiee, M., Rabiee, N., Ramezanzadeh, K., Rawaf, D. L., Rawaf, S., Rezaei, N., Robinson, S. R., Ronfani, L., Saxena, S., Sepehrimanesh, M., Shaikh, M. A., Sharafi, Z., Sharif, M., Siabani, S., Sima, A. R., Singh, J. A., Soheili, A., Sotoudehmanesh, R., Suleria, H. A. R., Tesfay, B. E., Tran, B., Tsoi, D., Vacante, M., Wondmieneh, A. B., Zarghi, A., Zhang, Z.-J., Dirac, M., Malekzadeh, R., & Naghavi, M.
- Affiliations
- University of Washington (US)
- Corresponding author
- Naghavi, Mohsen
- ORCID
- Alatab, Sudabeh
- Sepanlou, Sadaf G
- Ikuta, Kevin
- Vahedi, Homayoon
- Safiri, Saeid
- Abdoli, Amir
- Abolhassani, Hassan
- Almadi, Majid A H
- Anushiravani, Amir
- Arabloo, Jalal
- Atique, Suleman
- Awasthi, Ashish
- Badawi, Alaa
- Baig, Atif A A
- Bhala, Neeraj
- Bijani, Ali
- Biondi, Antonio
- Borzì, Antonio M
- Burke, Kristin E
- Carvalho, Félix
- Daryani, Ahmad
- Dubey, Manisha
- Eftekhari, Aziz
- Fernandes, Eduarda
- Fernandes, João C
- Fischer, Florian
- Hasanzadeh, Amir
- Hashemian, Maryam
- Hay, Simon I
- Hoang, Chi L
- Househ, Mowafa
- Ilesanmi, Olayinka S
- James, Spencer L
- Malekzadeh, Masoud M
- Merat, Shahin
- Meretoja, Tuomo J
- Mirrakhimov, Erkin M
- Mirzaei, Hamid
- Mohammad, Karzan A
- Mokdad, Ali H
- Monasta, Lorenzo
- Nguyen, Trang H
- Nguyen, Cuong T
- Pourshams, Akram
- Poustchi, Hossein
- Rabiee, Mohammad
- Rabiee, Navid
- Rawaf, David L
- Rawaf, Salman
- Rezaei, Nima
- Robinson, Stephen R
- Ronfani, Luca
- Saxena, Sonia
- Sepehrimanesh, Masood
- Shaikh, Masood A
- Sharafi, Zeinab
- Siabani, Soraya
- Sima, Ali Reza
- Soheili, Amin
- Sotoudehmanesh, Rasoul
- Suleria, Hafiz Ansar Rasul
- Tesfay, Berhe E
- Tran, Bach
- Vacante, Marco
- Wondmieneh, Adam B
- Zarghi, Afshin
- Zhang, Zhi-Jiang
- Dirac, Mae
- Malekzadeh, Reza
- Naghavi, Mohsen
- Venue
- The Lancet Gastroenterology & Hepatology
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 5
- Issue
- 1
- Pages
- 17-30
- ISSN
- 2468-1156 (ISSN-L)
- 2468-1253
- PMC
- PMC7026709
- OpenAlex
- W2981768636
- Cited by
- 2,313
- References
- 33
- Citations by year
- 2026: 232 · 2025: 373 · 2024: 445 · 2023: 460 · 2022: 374 · 2021: 300 · 2020: 123
- FWCI
- 120.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The Lancet. Gastroenterology & hepatology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Federal Open Science Repository of Canada / Le Dépôt fédéral de science ouverte du Canada (submittedVersion, cc-by)
- RMIT Research Repository (RMIT University Library) (submittedVersion, other-oa)
- Figshare (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- UTS ePRESS (University of Technology Sydney) (submittedVersion, other-oa)
- PUB – Publications at Bielefeld University (Bielefeld University) (submittedVersion, cc-by)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Funders
- Università di Catania
- Division of Cancer Epidemiology and Genetics, National Cancer Institute
- Trường Đại học Nguyễn Tất Thành
- Iran University of Medical Sciences
- Applied Molecular Biosciences Unit
- Public Health Institute
- Johns Hopkins University
- Urmia University of Medical Sciences
- Babol University of Medical Sciences
- University of Melbourne
- Queen Elizabeth Hospital Birmingham Charity
- Trường Đại học Y Hà Nội
- Universität Bielefeld
- Universidade do Porto
- National Cancer Institute
- Department of Radiology, Weill Cornell Medical College
- Guilan University of Medical Sciences
- College of Medicine, University of Florida
- Islamic Azad University
- Kashan University of Medical Sciences
- University of Birmingham
- UCLH Biomedical Research Centre
- Department of Chemistry, University of York
- Department of Biology, University of New Mexico
- Trường Đại học Duy Tân
- Amirkabir University of Technology
- University of Ibadan
- Utica College
- King Saud University
- McGill University
- Public Health Agency of Canada
- Kermanshah University of Medical Sciences
- Helsingin ja Uudenmaan Sairaanhoitopiiri
- Institute for Health Metrics and Evaluation
- Mazandaran University of Medical Sciences
- Hamad Bin Khalifa University
- Jahrom University of Medical Sciences
- Maragheh University of Medical Sciences
- Sharif University of Technology
- University of Louisiana at Lafayette
- Zanjan University of Medical Sciences
- Bill and Melinda Gates Foundation
- Ministério da Ciência, Tecnologia e Ensino Superior (UID/MULTI/04378/2019, UID/Multi/50016/2019, UID/QUI/50006/2019)
- Fuel Cell Technologies Program
- Department of Science and Technology, Ministry of Science and Technology, India
- University of Toronto
- University of Washington
- University of Cape Town
- Tabriz University of Medical Sciences
- University of Technology Sydney
- Department of Medicine, Georgetown University
- Shiraz University of Medical Sciences
- Medical Research Council
- Lorestan University of Medical Sciences
- Division of Gastroenterology and Hepatology, School of Medicine, Indiana University
- Addis Ababa University
- Razi Herbal Medicines Research Center
- School of Medicine
- Shahid Beheshti University of Medical Sciences
- College of Science and Engineering, University of Minnesota
- Public Health England
- School of Medicine and Public Health, University of Wisconsin-Madison
- Salahaddin University-Erbil
- University of Hail
- Department of Psychology, Western Washington University
- Babol Noshirvani University of Technology
- University of Alabama
- Wuhan University
- Massachusetts General Hospital
- Adigrat University
- Universiti Sultan Zainal Abidin
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Keywords
- inflammatory bowel disease, Crohn's disease, ulcerative colitis, disease burden, prevalence, mortality, years of life lost, years lived with disability, disability-adjusted life years, global health burden, regional variation, temporal trends, causes of death, risk factors
- MeSH terms
- Global Burden of Disease, Adult, Aged, Aged, 80 and over, Bayes Theorem, Cause of Death, Female, Humans, Male, Morbidity, Retrospective Studies, Socioeconomic Factors, Global Health, Inflammatory Bowel Diseases, Prevalence, Survival Rate, Quality-Adjusted Life Years
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. https://app.cochat.ai/papers/10.1016/s2468-1253(19)30333-4
- The paper
- Alatab, S., Sepanlou, S. G., Ikuta, K., Vahedi, H., Bisignano, C., Safiri, S., Sadeghi, A., Nixon, M. R., Abdoli, A., Abolhassani, H., Alipour, V., Almadi, M. A. H., Almasi-Hashiani, A., Anushiravani, A., Arabloo, J., Atique, S., Awasthi, A., Badawi, A., Baig, A. A. A., . . . Naghavi, M. (2020). The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(19)30333-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.